Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells - Relevance to the inflammatory reaction in atherogenesis

European Journal of Biochemistry

Volumn 236, Issue 1, 1996, Pages 48-55

  Dentan, C ^a   Lesnik, P ^a   Chapman, M J ^a   Ninio, E ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Acetylhydrolase; Atherogenesis; Cholesterol; Macrophage foam cells; Platelet activating factor

Indexed keywords

ACID HYDROLASE; ACYLTRANSFERASE; CHOLESTEROL; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CYTOCHEMISTRY; FOAM CELL; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0029983099     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1996.00048.x     Document Type: Article

References (60)

1. 1 Benveniste, J. (1988) Paf‐acether: an ether phospholipid with biological activity, prog. Clin. Biol. Res. 282, pp. 73–85.
2. 2 Bussolino, F. & Camussi, G. (1995) Platelet‐activating factor produced by endothelial cells–A molecule with autocrine and paracrine properties, Eur. J. Biochem. 229, 327–337.
3. 3 Ninio, E. & Joly, F. (1991) Transmembrane signalling and pafacether biosynthesis, Lipids 26, 1034–1037.
4. 4 Benveniste, J., Nunez, D., Duriez, P., Korth, R., Biolault, J. & Fruchart, J. C. (1988) Preformed paf‐acether and lyso paf‐acether are bound to blood lipoproteins, FEBS Lett. 226, 371–376.
5. 5 Honda, Z. I., Nakamura, M., Miki, I., Minami, M., Watanabe, T., Seyama, Y., Okado, H., Toh, H., Ito, K., Miyamoto, T. & Shimizu, T. (1991) Cloning by functional expression of platelet‐activating factor receptor from guinea‐pig lung, Nature 349, 342–346.
6. 6 Nakamura, M., Honda, Z. I., Izumi, T., Sakanaka, C., Mutoh, H., Minami, M., Bito, H., Seyama, Y., Matsumoto, T., Noma, M. & Shirnizu, T. (1991) Molecular cloning and expression of platelet‐activating factor receptor from human leukocytes, J. Biol. Chem. 266, 20400–20405.
7. 7 Thivierge, M., Alami, N., Müller, E., de Brum‐Fernandes, A. J. & Rola‐Pleszczynski, M. (1993) Transcriptional modulation of platelet‐activating factor receptor gene expression by cyclic AMP, J. Biol. Chem. 268, 17457–17462.
8. 8 Snyder, F. (1995) Platelet‐activating factor and its analogs: metabolic pathways and related intracellular processes, Biochim. Biophys. Acta 1254, 231–249.
9. 9 Elstad, M. R., Stafforini, D. M., McIntyre, T. M., Prescott, S. M. & Zimmerman, G. A. (1989) Platelet‐activating factor acetylhydrolase increase during macrophage differentiation: a novel mechanism that regulates accumulation of platelet‐activating factor, J. Biol. Chem. 264, 8467–8470.
10. 10 Korth, R., Biolault, J., Palmantier, R., Benveniste, J. & Ninio, E. (1993) Human platelets release a paf‐acether: acetylhydrolase similar to that in plasma, Lipids 28, 193–199.
11. 11 Tarbet, E. B., Stafforini, D. M., Elstad, M. R., Zimmerman, G. A., McIntyre, T. M. & Prescott, S. M. (1991) Liver cells secrete the plasma form of platelet‐activating factor acetylhydrolase, J. Biol. Chem. 266, 16667–16673.
12. 12 Stafforini, D. M., Prescott, S. M. & McIntyre, T. M. (1987) Human plasma platelet‐activating factor acetylhydrolase: purification and properties, J. Biol. Chem. 262, 4223–4230.
13. 13 Tselepis, T. A., Dentan, C., Karabina, S. A., Chapman, M. J. & Ninio, E. (1995) PAF‐degrading acetylhydrolase is preferentially associated with dense LDL and VHDL‐1 in human plasma: catalytic characteristics and relation to the monocyte‐derived enzyme, Arterioscler. Thromb. Vase. Biol. 15, 1764–1773.
14. 14 Tjoelker, L. W., Wilder, C., Eberhardt, C., Stafforini, D. M., Dietsch, G., Schimpf, B., Hooper, S., Letrong, H., Cousens, L. S., Zimmerman, G. A., Yamada, Y., Mcintyre, T. M., Prescott, S. M. & Gray, P. W. (1995) Anti‐inflammatory properties of a platelet‐activating factor acetylhydrolase, Nature 374, 549–553.
15. 15 Evangelou, A. M. (1994) Platelet‐activating factor (PAF)–implications for coronary heart and vascular diseases, Prostaglandins Leukotrienes Essent. Fatty Acids 50, 1–28.
16. 16 Mueller, H. W., Haught, C.A., Mcnatt, J. M., Cui, K. X., Gaskell, S. J., Johnston, D. A. & Willerson, J. T. (1995) Measurement of platelet‐activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease, Circ. Res. 77, 54–63.
17. 17 Feliste, R., Perret, B., Braquet, P. & Chap, H. (1989) Protective effect of BN 52021, a specific antagonist of platelet‐activating factor (PAF‐acether) against diet‐induced cholesteryl ester drposition in rabbit aorta, Atherosclerosis 78, 151–158.
18. 18 Rouis, M., Nigon, F., Lafuma, C., Hornebeck, W. & Chapman, M. J. (1990) Expression of elastase activity by human monocytemacrophages is modulated by cellular cholesterol content, inflammatory mediators, and phorbol myristate acetate. Arteriosclerosis 10, 246–255.
19. 19 Rouis, M., Nigon, F. & Chapman, J. (1988) Platelet‐activating factor is a potent stimulant of the production of active oxygen species by human monocyte‐derived macrophages, Biochem. Biophys. Res. Commun. 156, 1293–1301.
20. 20 Stewart, A. G., Dubbin, P. N., Harris, T. & Dusting, G. J. (1990) Platelet‐activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells, Proc. Natl Acad. Sci. USA 87, 3215–3219.
21. 21 Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature 362, 801–809.
22. 22 Goldstein, J. L., Ho, Y. K., Basu, S. K. & Brown, M. S. (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition, Proc. Natl. Acad. Sci. USA 76, 333–337.
23. 23 Hoff, H. F., Zyromski, N., Amistrong, D. & O'Neil, J. (1993) Aggregation as well as chemical modification of LDL during oxidation is responsible for poor processing in macrophages, J. Lipid Res. 34, 1919–1929.
24. 24 Lesnik, P., Rouis, M., Skarlatos, S., Kruth, H. S. & Chapman, M. J. (1992) Uptake of exogenous free cholesterol induced upregulation of tissue factor expression in human monocyte‐derived macrophages, Proc. Natl Acad. Sci. USA 89, 10370–10374.
25. 25 Falk, E., Shah, P. K. & Fuster, V. (1995) Coronary plaque disruption. Circulation 92, 657–671.
26. 26 Ninio, E., Maiza, H. & Biolault, J. (1993) Autocrine amplification of PAF‐acether formation in immunologically activated murine macrophages, J. Leukocyte Biol. 54, 296–299.
27. 27 Chapman, M. J., Laplaud, P. M., Luc, G., Forgez, P., Bruckert, E., Goulinet, S. & Lagrange, D. (1988) Further resolution of the low‐density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation, J. Lipid Res. 29, 442–458.
28. 28 Dentan, C., Lesnik, P., Chapman, M. J. & Ninio, E. (1994) PAF‐acether‐degrading acetylhydrolase in plasma LDL is inactivated by copper‐ and cell‐mediated oxidation, Arterioscler. Thromh. 14, 353–360.
29. 29 Basu, S. K., Goldstein, J. L., Anderson, R. G. W. & Brown, M. S. (1976) Degradation of cationized low‐density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts, Proc. Natl Acad. Sci. USA 73, 3178–3182.
30. 30 Noble, R. P. (1968) Electrophoretic separation of plasma lipoproteins in agarose gel, J. Lipid Res. 9, 693–700.
31. 31 Nakagawara, A., Nathan, C. F. & Cohn, Z. A. (1981) Hydrogen peroxide metabolism in human monocytes during differentiation in vitro, J. Clin. Invest. 68, 1243–1252.
32. 32 Gamble, W., Vaughan, M., Kruth, H. S. & Avigan, J. (1978) Procedure for determination of free and total cholesterol in micro or nanogram amounts suitable for studies with cultured cells, J. Lipid Res. 19, 1068–1070.
33. 33 Burton, K. (1956) A study of the conditions and mecanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid, Biochem. J. 62, 315–323.
34. 34 Leyravaud, S., Bossant, M. J., Joly, F., Bessou, G., Benveniste, J. & Ninio, E. (1989) Biosynthesis of paf‐acether. X. Phorbol myristate acetate‐induced paf‐acether biosynthesis and acetyltransferase activation in human neutrophils. J. Immunol. 143, 245–249.
35. 35 Bossant, M. J., Ninio, E., Delautier, D. & Benveniste, J. (1990) Bioassay of platelet‐activating factor acether by rabbit platelet aggregation, Methods Enzymol. 187, 125–130.
36. 36 Nunez, D., Chignard, M., Korth, R., Le Couedic, J. P., Norel, X., Spinnewyn, B., Braquet, P. & Benveniste, J. (1986) Specific inhibition of paf‐acether induced platelet activation by BN 52021 and comparison with the paf‐acether inhibitors kadsurenone and CV 3988, Eur. J. Pharmacol. 123, 197–205.
37. 37 Cazals‐Stenzel, J. & Weber, K. (1987) Triazolodiazepines: dissociation of their PAF (platelet‐activating factor) antagonistic and CNS activity, Br. J. Pharmacol. 90, 139–146.
38. 38 Benveniste, J., Le Couedic, J. P., Polonsky, J. & Tencé, M. (1977) Structural analysis of purified platelet‐activating factor by lipases, Nature 269, 170–171.
39. 39 Tencé, M., Polonsky, J., Le Couedic, J. P. & Benveniste, J. (1980) Release, purification and characterization of platelet‐activating factor (PAF), Biochimie (Paris) 62, 251–259.
40. 40 Ninio, E., Mencia‐Huerta, J.‐M. & Benveniste, J. (1983) Biosynthesis of platelet‐activating factor (paf‐acether). V. Enhancement of acetyltransferase activity in murine peritoneal cells by calcium ionophore A23187, Biochim. Biophys. Acta 751, 298–304.
41. 41 Palmantier, R., Dulioust, A., Maïza, H., Benveniste, J. & Ninio, E. (1989) Biosynthesis of paf‐acether. Paf‐acether output in murine peritoneal macrophages is regulated by the level of acetylhydrolase, Biochem. Biophys. Res. Commun. 162, 475–482.
42. 42 Worthen, G. S., Seccombe, J. F., Clay, K. L., Guthrie, L. A. & Johnston, R. B. (1988) The priming of neutrophils by lipopolysaccharide for production of intracellular platelet‐activating factor. Potential role in mediation of enhanced superoxide secretion, J. Immunol. 140, 3553–3559.
43. 43 Narahara, H., Frenkel, R. A. & Johnston, J. M. (1993) Secretion of platelet‐activating factor acetylhydrolase following phorbol ester‐stimulated differentiation of HL‐60 cells, Arch. Biochem. Biophys. 301, 275–281.
44. 44 Jouvin‐Marche, E., Ninio, E., Beaurain, G., Tence, M., Niaudet, P. & Benveniste, J. (1984) Biosynthesis of paf‐acether (platelet‐activating factor). VII. Precursors of paf‐acether and acetyl‐transferase activity in human leukocytes, J. Immunol. 133, 892–898.
45. 45 Rouis, M., Nigon, F., Eggerman, T. L., Brewer, H. B. & Chapman, M. J. (1990) Apolipoprotein E expression by human‐monocytederived macrophages. Modulation by opsonised zymosan and cholesterol, Eur. J. Biochem. 189, 447–453.
46. 46 Roubin, R., Dulioust, A., Haye‐Legrand, I., Ninio, E. & Benveniste, J. (1986) Biosynthesis of paf‐acether. VIII. Impairment of paf‐acether production in activated macrophages does not depend upon acetyltransferase activity, J. Immunol. 136, 1796–1802.
47. 47 Colard, O., Biolault, J., Breton, M. & Ninio, E. (1993) Biosynthesis of platelet‐activating factor in cultured mast cells. Involvement of the CoA‐independent transacylase demonstrated by analysis of the molecular species of platelet‐activating factor, Eur. J. Biochem. 216, 835–840.
48. 48 Lee, T. C., Malone, B., Wasserman, S. I., Fitzgerald, V. & Snyder, F. (1982) Activities of enzymes that metabolize platelet‐activating factor (1‐alkyl‐2–acetyl‐ sn ‐glycero‐3–phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore, Biochem. Biophys. Res. Commun. 105, 1303–1308.
49. 49 Ninio, E., Leyravaud, S., Biolauk, J., Jurgens, P. & Benveniste, J. (1991) Cell adhesion by membrane‐bound‐paf‐acether, Int. Immunol. 3, 1157–1163.
50. 50 Weyrich, A. S., McIntyre, T. M., McEver, R. P., Prescott, S. M. & Zimmermann, G. A. (1995) Monocyte tethering by P‐selectin regulates monocyte chemotactic protein‐1 and tumor necrosis factor‐α secretion. Signal integration and NF‐κB translocation, J. Clin. Invest. 95, 2297–2303.
51. 51 Mueller, H. W., O'Flaherty, J. T. & Wykle, R. L. (1984) The molecular species distribution of platelet‐activating factor synthesized by rabbit and human neutrophils, J. Biol. Chem. 259, 14554–14559.
52. 52 Mac Manus, L. M., Woodard, D. S., Deavers, S. I. & Pinckard, R. N. (1993) Biology of disease. Paf molecular heterogeneity: pathobiological implications, Lab. Invest. 69, 639–650.
53. 53 Tencé, M., Coeffier, E., Heymans, F., Polonsky, J., Codfroid, J. J. & Benveniste, J. (1981) Structural analogs of platelet‐activating factor (PAF‐acether), Biochimie (Paris) 63, 723–727.
54. 54 Montrucchio, G., Lupia, E., Battaglia, E., Passerini, G., Bussolino, F., Emanuelli, G. & Camussi, G. (1994) Tumor necrosis factor α‐induced angiogenesis depends on in situ platelet‐activating factor biosynthesis, J. Exp. Med. 180, 377–382.
55. 55 Handley, D. A., Arbeeny, C. M., Lee, M. L., Van Valen, R. G. & Saunders, R. N. (1984) Effect of platelet‐activating factor on endothelial permeability to plasma macromolecules, Immunopharmacology 8, 137–142.
56. 56 Emeis, J. J. & Kluft, C. (1985) PAF‐acether‐induced release of tissue‐type plasminogen activator from vessel walls, Blood 66, 86–91.
57. 57 Schmid, E., Muller, T. H., Budzinski, R. M., Pfizenmaier, K. & Binder, K. (1995) Lymphocyte adhesion to human endothelial cells induces tissue factor expression via a juxtacrine pathway, Thromb. Haemostasis 73, 421–428.
58. 58 Pan, Z. X., Kravchenko, V. V. & Ye, R. D. (1995) Platelet‐activating factor stimulates transcription of the heparin‐binding epidermal growth factor‐like growth factor in monocytes–Correlation with an increased kappa B binding activity, J. Biol. Chem. 270, 7787–7790.
59. 59 Voelker, N. F., Worthen, S., Reeves, J. T. & Henson, H. M. (1982) Nonimmunological production of leukotrienes induced by platelet‐activating factor, Science 218, 286–288.
60. 60 Liapikos, T. A., Smaragda, A., Karabina, S. A., Tsoukatos, D. C., Demopoulos, C. A. & Tselepis, A. D. (1994) Platelet‐activating factor formation during oxidative modification of low‐density lipoprotein when PAF‐acetylhydrolase has been inactivated, Biochim. Biophys. Acta 1212, 353–360.